← Coming soon·

REG1V Revenio Group Oyj

OMXH25 · Helsinkisingle-model previewUpdated 2026-07-11

Single AI model preview (DeepSeek): Revenio Group Oyj estimate 15.70 € vs market price 12.48 € (+25.8%). Analyst coverage: 4. Experimental research — not investment advice.

Spot
12.48 €
Preview est.
15.70 €
Gap
+25.8%
Analysts
4
Market cap
363 M €
52-week range
12.02 €29.10 €
Sector
healthcare

About the company

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by veterinarians, ophthalmologists and other personnel to measure intraocular pressure in animal patients. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combi

Source: Yahoo Finance

Model assumptions (DeepSeek)

Revenue CAGR (5y)
4.0 %
EBIT margin target
23.0 %
WACC
8.0 %
Terminal growth
2.0 %
Model confidence
65 %
The estimate runs these assumptions through the same deterministic valuation engine as the live universe. Valuation Methodology

Weekly snapshots

12131415162.7.3.7.4.7.11.7.
SpotPreview est.
DateSpotPreview est.Gap
2026-07-1112.48 €15.70 €+25.8%
2026-07-0412.54 €15.53 €+23.8%
2026-07-0312.46 €15.53 €+24.6%
2026-07-0212.32 €16.14 €+31.0%
Experimental research — not investment advice. Preview estimates come from a single AI model and differ from the live 5-model consensus.